12:00 AM
 | 
Mar 22, 1999
 |  BC Week In Review  |  Company News  |  Deals

BioChem, OSI deal

OSIP granted to BCHE exclusive worldwide rights to antiviral assays, reagents and lead compounds that the companies jointly developed...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >